Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from EC Healthcare ( (HK:2138) ) is now available.
EC Healthcare has issued a profit warning, indicating a potential decrease in revenue, EBITDA, and net profit for the six months ending September 2025. This decline is attributed to weak local consumption sentiment, reduced revenue from disposed medical assets, and a less favorable service mix. Despite these challenges, the company maintains a strong balance sheet with significant cash reserves.
The most recent analyst rating on (HK:2138) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on EC Healthcare stock, see the HK:2138 Stock Forecast page.
More about EC Healthcare
EC Healthcare operates in the healthcare industry, focusing on providing medical and wellness services. The company is known for its discretionary medical and aesthetic service categories, with a market focus on Hong Kong and Mainland China.
Average Trading Volume: 624,439
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$711.1M
See more data about 2138 stock on TipRanks’ Stock Analysis page.